β-catenin gets jaded and von Hippel-Lindau is to blame

Trends in Biochemical Sciences

Volumn 34, Issue 3, 2009, Pages 101-104

  Berndt, Jason D ^a   Moon, Randall T ^a   Major, Michael B ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HOMEODOMAIN PROTEIN; JADE 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN; WNT PROTEIN;

CARCINOGENESIS; CLEAR CELL CARCINOMA; ENZYME ACTIVITY; GENE REPRESSION; HUMAN; KIDNEY CARCINOMA; NEPHROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SHORT SURVEY; SIGNAL TRANSDUCTION; UBIQUITINATION;

BETA CATENIN; CARCINOMA, RENAL CELL; HOMEODOMAIN PROTEINS; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 62849095830     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2008.12.002     Document Type: Short Survey

References (20)

1. Moon R.T., et al. WNT and β-catenin signaling: diseases and therapies. Nat. Rev. Genet. 5 (2004) 691-701
2. Chitalia V.C., et al. Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL. Nat. Cell Biol. 10 (2008) 1208-1216
3. Kimelman D., and Xu W. β-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25 (2006) 7482-7491
4. Zhou M.I., et al. Jade-1, a candidate renal tumor suppressor that promotes apoptosis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 11035-11040
5. Zhou M.I., et al. Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent. Cancer Res. 64 (2004) 1278-1286
6. Zhou M.I., et al. The von Hippel-Lindau tumor suppressor stabilizes novel plant homeodomain protein Jade-1. J. Biol. Chem. 277 (2002) 39887-39898
7. 2 sensing and cancer. Nat. Rev. Cancer 8 (2008) 865-873
8. Lim J.H., et al. Hypoxia-inducible factor-1α obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of β-catenin. Cancer Res. 68 (2008) 5177-5184
9. Kaidi A., et al. Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9 (2007) 210-217
10. Peruzzi B., et al. The von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14531-14536
11. Lonser R.R., et al. von Hippel-Lindau disease. Lancet 361 (2003) 2059-2067
12. Major M.B., et al. Wilms tumor suppressor WTX negatively regulates WNT/β-catenin signaling. Science 316 (2007) 1043-1046
13. Rivera M.N., et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315 (2007) 642-645
14. Kuehn E.W., et al. Von Hippel-Lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development. Cancer Res. 67 (2007) 4537-4540
15. Rodova M., et al. The polycystic kidney disease-1 promoter is a target of the β-catenin/T-cell factor pathway. J. Biol. Chem. 277 (2002) 29577-29583
16. Huan Y., and van Adelsberg J. Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J. Clin. Invest. 104 (1999) 1459-1468
17. He X. Cilia put a brake on Wnt signalling. Nat. Cell Biol. 10 (2008) 11-13
18. Qian C.N., et al. Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. J. Biol. Chem. 280 (2005) 3938-3945
19. Foy R.L., et al. Role of Jade-1 in the hat HBO1 complex. J. Biol. Chem. 283 (2008) 28817-28826
20. Panchenko M.V., et al. von Hippel-Lindau partner Jade-1 is a transcriptional co-activator associated with histone acetyltransferase activity. J. Biol. Chem. 279 (2004) 56032-56041